83 results
S-1/A
EX-99.2
CELU
Celularity Inc - Ordinary Shares
13 May 19
IPO registration (amended)
4:55pm
. In determining the long-term incentive component of the Chief Executive Officer’s compensation, the Committee shall consider factors as it determines … independent directors (as directed by the Board), determine and approve the compensation of such other executive officers. To the extent that long-term incentive
425
EX-99.1
CELU
Celularity Inc - Ordinary Shares
18 Mar 21
Business combination disclosure
8:02am
malignant brain tumor. Currently there are no effective long-term treatments for the disease. Patients with GBM have a poor prognosis and usually
8-K
EX-99.1
CELU
Celularity Inc - Ordinary Shares
18 Mar 21
Other Events
8:03am
malignant brain tumor. Currently there are no effective long-term treatments for the disease. Patients with GBM have a poor prognosis and usually
424B3
CELU
Celularity Inc - Ordinary Shares
24 Aug 22
Prospectus supplement
4:54pm
companies” or “controlled foreign corporations” within the meaning of the Code, and former U.S. citizens or long-term residents.
In addition, this discussion … . Holder will generally constitute “qualified dividends” that will be subject to tax at long-term capital gains rates. If the requirements
8-K
EX-99.1
CELU
Celularity Inc - Ordinary Shares
28 Dec 21
Celularity Receives Fast Track Designation from U.S. FDA for its NK Cell Therapy CYNK-001 in Development for the Treatment of AML
4:01pm
of acute myeloid leukemia (AML).
“The majority of patients with AML continue to have poor long-term outcomes, particularly those who suffer relapse
424B3
ml000gwv cyq9a8r
24 Aug 22
Prospectus supplement
4:52pm
POS AM
3iznt6pylabdl5rusgt
11 Aug 22
Prospectus update (post-effective amendment)
4:20pm
POS AM
rpnl6d
11 Aug 22
Prospectus update (post-effective amendment)
4:23pm
424B3
hssyy4aa obpbisetrk
2 Jun 23
Prospectus supplement
5:00pm
8-K
EX-99.1
9obqw 0fp3c4z
22 Jul 21
Celularity Closes Merger with GX Acquisition Corp and Provides Corporate Update
4:13pm
425
n5ipx2br76df6qip0y
13 Apr 21
Business combination disclosure
1:01pm
424B3
t76dem f4b
28 Dec 21
Prospectus supplement
4:05pm
425
6eqr d1p48ca
15 Jun 21
Business combination disclosure
12:00am
8-K
EX-99.2
rq1w71
22 Jul 21
Celularity Closes Merger with GX Acquisition Corp and Provides Corporate Update
4:13pm
8-K/A
EX-99.5
cpwwuzb1
20 Aug 21
Financial Statements and Exhibits
12:00am
424B3
neeqwk9q8 11d
12 Aug 21
Prospectus supplement
4:21pm
8-K/A
EX-99.3
3nj a9j9iz
16 Aug 21
Completion of Acquisition or Disposition of Assets
5:23pm